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Chronic Arsenic Exposure and Angiogenesis in Human Bronchial Epithelial
Cells via the ROS/miR-199a-5p/HIF-1α/COX-2 Pathway
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Background: Environmental and occupational exposure to arsenic is a major public health
concern. Although it has been identified as a human carcinogen, the molecular mechanism
underlying the arsenic-induced carcinogenesis is not well understood.
Objectives: We aimed to determine the role and mechanisms of miRNAs in arsenic-induced tumor
angiogenesis and tumor growth.
Methods: We utilized an in vitro model in which human lung epithelial BEAS-2B cells were transformed through long-term exposure to arsenic. A human xenograft tumor model was established
to assess tumor angiogenesis and tumor growth in vivo. Tube formation assay and chorioallantoic
membranes assay were used to assess tumor angiogenesis.
Results: We found that miR-199a-5p expression levels were more than 100-fold lower in arsenictransformed cells than parental cells. Re-expression of miR-199a-5p impaired arsenic-induced
angiogenesis and tumor growth through its direct targets HIF-1α and COX-2. We further showed
that arsenic induced COX-2 expression through HIF-1 regulation at the transcriptional level. In
addition, we demonstrated that reactive oxygen species are an upstream event of miR-199a-5p/
HIF-1α/COX-2 pathway in arsenic-induced carcinogenesis.
Conclusion: The findings establish critical roles of miR-199a-5p and its downstream targets
HIF-1/COX-2 in arsenic-induced tumor growth and angiogenesis.
Citation: He J, Wang M, Jiang Y, Chen Q, Xu S, Xu Q, Jiang BH, Liu LZ. 2014. Chronic arsenic
exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1α/
COX-2 Pathway. Environ Health Perspect 122:255–261; http://dx.doi.org/10.1289/ehp.1307545

Introduction
Arsenic is a widely distributed semimetallic
element that occurs naturally in various compounds in the crust of the earth. Approximately
160 million people worldwide are exposed to
unsafe high levels of arsenic in drinking water
(Hubaux et al. 2013). In particular, about
25 million people in Bangladesh and 6 million in India are chronically exposed to a very
high level of arsenic exceeding 50 μg/L via
groundwater (Rahman et al. 2001), which is
significantly greater than the current maximum
contaminant level (MCL) of 10 μg/L set forth
by the U.S. Environmental Protection Agency
(2014). Long-term arsenic exposure leads to an
increased risk of skin, bladder, and liver cancers
and, especially, lung cancer. Epidemiological
investigations and laboratory studies have provided evidence that ingestion of arsenic via
drinking water or inhalation of air increases
the risk of lung cancer in a dose–dependent
way (Boffetta 2004; Chen et al. 2004).
However, the exact mechanism of arsenicinduced cell malignant transformation and
cancer development remains to be investigated.
Current proposed mechanisms underlying
arsenic carcinogenesis include arsenic-induced
genetic changes and epigenetic alterations
(Hubaux et al. 2013). The epigenetic alterations consist of histone modification, DNA
methylation, and microRNA (miRNA)
Environmental Health Perspectives •
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regulation. We and others (Beezhold et al.
2011; He et al. 2013b; Wang et al. 2011) have
observed aberrant miRNA expression profiles
after heavy-metal exposure in various cell types,
which indicates the involvement of miRNAs
in environmental carcinogenesis. However,
it remains to be determined whether these
miRNAs play causal roles in arsenic-induced
tumor initiation and development.
Angiogenesis is the formation of new
blood vessels from existing vasculatures to
induce tumor growth. Outside of its role
in physiological processes such as embryo
developm ent and wound healing, angiogenesis is required for cancer development.
Angiogenesis is critical for a tumor colony to
grow and become invasive (D’Amico 2004).
In the present study, we aimed to determine
a) the roles of miRNAs in arsenic-induced
tumor angiogenesis and tumor growth,
b) the direct targets of miRNAs in regulating tumorigenesis, and c) the functional
relevant angiogenesis factors in arsenic- and
miRNA-mediated carcinogenesis.

Materials and Methods
Cell culture and generation of stable cell lines.
Human bronchial epithelial BEAS-2B cells
[American Type Culture Collection (ATCC),
Manassas, VA, USA] were cultured in DMEM
(Dulbecco’s modiﬁed Eagle’s medium;
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Invitrogen, Carlsbad, CA, USA) supplemented
with 10% fetal bovine serum (FBS). Human
umbilical vein endothelial cells (HUVEC)
(purchased from ATCC) were cultured in
EBM-2 (endothelial basal medium-2) complete medium. Arsenic-transformed BEAS-2B
(AsT) cells (Carpenter et al. 2011) stably over
expressing miR-199a or miR-control were
generated by infecting BEAS-2B cells with
lentivirus carrying miR-199a-RFP or a negative control precursor (Applied Biosystems,
Carlsbad, CA, USA), followed by selection
with puromycin. To establish stable cell lines
overexpressing COX-2 (cyclooxygenase-2),
293T cells were transfected with lentivirus
carrying the COX-2 plasmid (GeneCopoeia,
Rockville, MD, USA) or an empty vector
to generate infectious virus. Then AsT cells
were transduced with virus, followed by the
puromycin selection. We also prepared PI3K
(phosphatidylinositide 3-kinase)–transformed
chicken embryo fibroblast cells as was
previously described (Chang et al. 1997; Jiang
et al. 2000).
Animal experiment. Female CrTac:NCrFoxn1nu mice (8 weeks of age) were purchased
from Taconic (Hudson, NY, USA), and maintained in pathogen-free conditions. Animals
were housed in sterilized cages (5 mice/cage)
with hardwood chip bedding. Standardized
commercial diets were provided, and sterilized water was available at all times. The
average weight of animals on arrival was
20 ± 2 g (mean ± SD). A total of 2 × 106
AsT/miR-cont cells or AsT/miR-199a cells
(AsT cells stably overexpressing miR-control
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or miR-199a, respectively) in 80 μL were
injected subcutaneously into the flanks of nude
(nu/nu) mice (n = 10/group). The animals used
in research were treated humanely according to the Institutional Animal Care and Use
Committee of Thomas Jefferson University.
The mice were euthanized by decapitation
6 weeks after injection. Tumor tissues were
removed and weighed. Parts of tissues were
paraffin-embedded, and other parts were snapfrozen in liquid nitrogen and stored at –80°C
for immunohistochemical analysis.
Reagents and antibodies. Sodium arsenic,
catalase, and H 2O 2 were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Small
interfering RNA (siRNA) Smartpools (pools
of four individual siRNAs) against COX-2,
HIF-1α (hypoxia inducible factor 1, alpha),
and a scrambled control were purchased
from Dharmacon (Lafayette, CO, USA).
COX-2 antibody was from Cell Signaling
Technology (Beverly, MA, USA). CD31
(platelet/endothelial cell adhesion molecule 1)
antibody for analyzing paraffin-embedded
tissues was from Santa Cruz Biotechnology
(Santa Cruz, CA, USA) and for analyzing
frozen tissues, from BD Pharmingen (San
Jose, CA, USA). HIF-1α antibody was from
BD Biosciences (Franklin Lakes, NJ, USA),
and α-SMA (smooth muscle α-actin) antibody was obtained from Abcam (Cambridge,
MA, USA). Primary antibodies used for
Western analysis were diluted 1:1,000 in 5%
bovine serum albumin as a working concentration and were incubated on a shaker
overnight at 4°C.
RT-qPCR analysis. Total RNAs were
extracted using Trizol (Life Technologies,
Carlsbad, CA, USA). The synthesis of cDNA
was performed using oligo (dT)18 primers
and M-MLV (Moloney Murine Leukemia
Virus) reverse transcriptase (Promega,
Madison, WI, USA). The amplification
was performed by polymerase chain reaction (PCR). SYBR-green reverse transcription PCR (RT-qPCR) was performed to
detect COX-2 and GADPH (glyceraldehyde3-phosphate dehydrogenase) mRNA levels
using the Power SYBR Green PCR Master
Mix Kit (Applied Biosystems). Taqman
RT-qPCR was performed to detect miRNA
expression levels using the Taqman miRNA
Reverse Transcription kit and Taqman universal PCR Master Mix (Applied Biosystems).
The sequences of primer used for SYBR-green
RT-qPCR were as follows:
• COX-2 forward: 5´-TCAGCCATACAGC
AAATCCTT-3´
• C O X - 2 r e v e r s e : 5 ´ - C T G C A C T G
TGTTAGTGG-3´
• GAPDH forward: 5´-ATGGGTGTGAAC
CATGA GAAGTATG-3´
• G A D P H r e v e r s e : 5 ´ G G T G C A G G
AGGCATTGCT-3´.
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Immunohistochemistry and immuno
fluorescence. Paraffin-embedded tissue sections
and frozen tissue sections were prepared by
routine methods (Fero Lab, Fred Hutchinson
Cancer Research Center 2011). For immuno
histochemistry, the Dako Envision two-step
method of immunohistochemistry was used
to stain CD31 (1:100 dilution) and α-SMA
(1:150 dilution) in xenograft tumor tissues as
described previously (He et al. 2012a). Tissue
sections were incubated with primary antibodies in a humid chamber overnight at 4°C.
The microvessel density reflected by CD31positive staining was counted in three different
fields per section. For immunofluorescence
staining, frozen sections were incubated with
primary antibodies overnight. Goat antirabbit or anti-mouse IgG conjugated with
fluorescein isothiocyanate or Texas Red (both
from Santa Cruz Biotechnology) (1:200 dilution) were used as secondary antibodies and
incubated for 2 hr at room temperature. Slides
were mounted with anti-fade DAPI reagent
(Invitrogen, Grand Island, NY, USA).
Chromatin immunoprecipation (ChIP)–
quantitative PCR (qPCR). ChIP-qPCR was
performed using the EpiTect ChIP OneDay
Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer’s instructions.
HIF-1α antibody (Abcam) was used to pull
down the protein–chromatin complexes.
Rabbit IgG was used as a negative control.
The immunoprecipated DNA was quantified using SYBR Green qPCR (Applied
Biosystems). All results were normalized to
1% input value of the same sample. COX-2
primers flanking the hypoxia-response elements (HRE) for SYBR Green qPCR were
as follows:
• Forward: 5´-TATA C AGC C TAT T AAG
CGTCGTCA-3´
• Reverse: 5´-CGTG T CTG G TCT G TAC
GTCTTAG-3´.
Prostaglandin E2 (PGE2) ELISA. Cells
were plated at 0.1 × 10 6 cells/well of a
24-well plate and allowed to recover overnight. The following day, the media were
replaced with fresh media, and then the cells
were cultured in normoxia or hypoxia (1%
O2) for 24 hr. The conditioned media were
then collected and cleared of cellular debris
by centrifugation at 2,000 rpm for 2 min.
PGE2 concentrations were determined using
the Prostaglandin E2 EIA Kit–Monoclonal
ELISA kit (no. 514010; Cayman Chemical,
Ann Arbor, MI, USA) according to the manufacturer’s instructions.
miRNA luciferase reporter constructs and
luciferase activity assay. The 3´UTR-luciferase
reporter constructs containing the 3´UTR
regions of COX-2 with wild-type and mutant
binding sites of miR-199a were amplified
using the PCR method (GoTaq® G2 Flexi
DNA Polymerase; Promega) according to the
volume

manufacturer’s instructions. The PCR products were cloned into the pMiR-luc luciferase
reporter vector (Ambion, Grand Island, NY,
USA). The mutant 3´UTR constructs were
made by introducing four point mutations
into the putative seed regions of COX-2. All
the constructs containing 3´UTR inserts were
sequenced and verified. The luciferase activity
assay was performed as previously described
(He et al. 2013a).
Site-directed mutagenesis. The human
full-length COX-2 reporter used was a generous gift from J. Li (Harvard University,
Boston, MA, USA) (Wu et al. 2006). To generate the HRE-mutant COX-2 reporter, we
performed site-directed mutagenesis on the
wild-type COX-2 reporter at the potential
HIF-1α binding sites with 3 base pair substitutions as previously described (Jiang et al.
1996). The mutant COX-2 reporter construct
was validated by DNA sequencing.
Tube formation assay. HUVEC were
cultured in EBM-2 complete medium, and
switched to EBM-2 basal medium containing
0.2% FBS for 24 hr before performing the
tube formation assay. The conditioned media
were prepared from different cells by replacing
normal culture medium with serum-reduced
medium (1% FBS). After culture for 24 hr,
the serum-reduced media were collected and
stored at –20°C for later use. The HUVEC
were trypsinized, counted, and resuspended in
EBM-2 basic medium; then they were mixed
with an equal volume of the conditioned
medium and seeded on Matrigel-pretreated
96-well plates at 2 × 104 cells/well. After culture for 6-12 hr, tube formation was observed
under a light microscope and photographed.
The total lengths of the tubes in each well were
measured using CellSens Standard software
(Olympus; Hamburg, Germany).
The chorioallantoic membranes (CAM)
assay. White Leghorn fertilized chicken eggs
(Charles River, Malvern, PA, USA) were incubated at 37°C under constant humidity. Cells
were transfected with miRNA precursors, or
treated as specifically indicated in the figure
legends. After transfection for 12 hr, the cells
were trypsinized, counted, and resuspended in
the serum-free medium. The cell suspensions
were mixed with Matrigel at a 1:1 ratio, and
implanted onto the CAM of chicken eggs on
day-9 embryos. Tumor angiogenesis responses
were analyzed 5 days after the implantation.
The tumor/Matrigel plugs were trimmed off
the CAM and photographed. The number
of blood vessels as the index of angiogenesis
was analyzed by counting the branches of
blood vessels in three representative areas
(each 1.0 mm2) by two observers in a double
blind manner.
miRNA transfection. Cells were cultured in 6-well plates to reach a 60% con
fluency, and transfected using miR-199a or a
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transformed cells compared with the parental
control cells, but the difference was not statistically significant (see Supplemental Material,
Figure S1). We also used newly transformed
immortalized RE3K rat kidney cells [by N-Ras
(neuroblastoma Ras)] (Kolligs et al. 1999)
(see Supplemental Material, Figure S2A).

We found that miR-199a expression levels
in N-Ras–transformed cells were 1.9-fold
lower compared with the control cells (see
Supplemental Material, Figure S2B), indicating that transformation and/or oncogenes
may decrease miR-199a expression. However,
given that miR-199a expression levels were
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Figure 1. miR-199a is down-regulated in AsT cells. (A) miR-199a expression levels were determined by
Taqman RT-qPCR in AsT cells and BEAS-2B (B2B) cells. (B) B2B cells were treated with sodium arsenic
at different concentrations for 24 hr. miR-199a expression levels were determined by RT-qPCR. Data are
presented as mean ± SE and analyzed by Student’s t-test.
*p < 0.05, compared with control cells.
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miR-199a-5p is down-regulated in AsT
cells. In order to investigate the mechanism
of arsenic-induced carcinogenesis, we previously established an in vitro model by transforming immortalized human lung epithelial
BEAS-2B cells via chronic exposure to 1 μM
sodium arsenic for 26 weeks (Carpenter et al.
2011). BEAS-2B cells cultured in arsenicfree medium served as a passage-m atched
control. We performed miRNA microarray
analysis to compare the miRNA profiles
between parental cells (BEAS-2B) and AsT
cells. We found that miR-199a (referred to
miR-199a-5p) was the most down-regulated
miRNA among the list of miRNAs examined (data not shown). We further validated
the result by performing Taqman RT-qPCR
analysis. As shown in Figure 1A, miR-199a
was 100-fold lower in AsT cells, indicating a
major change of miRNA abundance in cell
malignant transformation (He et al. 2013b).
To investig ate the relationship between
arsenic treatment and miR-199a expression, we treated BEAS-2B cells with sodium
arsenic at the doses of 0.5 μM, 1 μM, and
2 μM for 24 hr. miR‑199a expression levels
were significantly decreased by arsenic treatment at the dose of ≥ 1 μM (Figure 1B). To
determine whether cell transformation affects
miR-199a expression, we tested two different types of cell lines transformed by oncogenes: the AsT cells and PI3K–transformed
chicken embryo fibroblast cells described
above. miR-199a levels were decreased in

*

0.4

Tumor weight (g)

negative-control precursor (both from Applied
Biosystems) at 30 nM using Lipofectamine
RNAiMAX reagent (Invitrogen, Grand Island,
NY, USA) according to the manufacturer’s
instructions. Total proteins and RNAs were
prepared from the cells 60–70 hr after the
transfection, followed by Western blotting or
RT-PCR analysis.
Hypoxia treatment. A hypoxia incubator chamber (Stemcell, Vancouver, British
Columbia, Canada) was used to generate the
hypoxia environment for cell culture. Cells
were cultured in hypoxia conditions (1% O2)
for 24 hr at 37°C.
Reactive oxygen species (ROS) study. Cells
were treated with ROS scavenger catalase
(1,500 U) or with H2O2 (50 μM) for 12 hr.
Then cells were harvested, and total proteins
were extracted for Western blotting analysis.
Statistical analysis. All the results were
obtained from at least three independent
experiments. Results are presented as
mean ± SE and were analyzed by Student’s
t-test or one-way analyis of variance
(ANOVA). All results were analyzed by SPSS
for Windows, version 11.5 (IBM, Chicago,
IL, USA). Differences were considered
significant with p < 0.05.
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Figure 2. miR-199a inhibits arsenic-induced angiogenesis. (A) HUVEC cells were cultured in serumfree medium overnight and resuspended in basic EBM-2 medium. Data represent mean ± SE from six
replicates from each treatment and were analyzed by one-way ANOVA. Bar = 500 μM. (B) Weight of
xenograft tumors from nude mice was measured 6 weeks after cell injection. Data represent mean ± SE
(n = 10/group). (C) Paraffin-embedded tumor tissue sections from both groups were used for immunohistochemical staining using antibodies against CD31. Top: representative sections (magnification: 160×;
bar = 50 μM). Bottom: quantification of microvessel density (MVD) indicated by CD31 staining in tumor
sections. Data represent mean ± SE from five different tumor sections from each group. (D) Frozen tissue
sections were used for immunofluorescence staining (magnification: 200×; bar = 50 μM). (E) Paraffinembedded tumor tissue sections were used for immunohistochemical staining using antibodies
against α-SMA. Representative sections are shown. Arrow indicates mural cells (magnification: 320×;
bar = 50 μM).
*p < 0.05, compared with B2B. #p < 0.05, compared with AsT/miR-cont.
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Indeed, overexpression of miR-199a in AsT
suppressed HIF-1α expression (Figure 3B).
Interestingly, we noticed that miR-199a
was also capable of down-regulating COX-2
expression. To explore whether COX-2 can
be directly targeted by miR-199a, we used
the “target search” process to predict possible binding sites and free minimal energy
of bindings and found that COX-2 is a putative target of miR-199a with two potential
binding regions. COX-2 3´UTR luciferase
reporters containing two putative miR-199a
binding sites were constructed to validate
the direct binding between COX-2 mRNA
3´UTR and miR-199a. Co-transfection of
miR-199a precursor with wild-type reporter
constructs containing binding sites (COX-2
3´UTR 311/320) greatly decreased the luciferase activities in BEAS-2B cells, whereas cotransfection with the corresponding reporter
containing point mutant at putative miR199a binding sites did not affect the luciferase
activities (Figure 3C). The luciferase activity in reporters containing putative binding
sites in COX-2 3´UTR from 2021 to 2029
was not affected by miR-199a, which suggests that this computation-predicted site

is not functionally targeted by miR-199a
(Figure 3D). Consistently, the expression
levels of COX-2 in xenograft tumors were
generally lower in AsT/miR-199a groups than
those in AsT/miR-cont groups (Figure 3E).
These findings demonstrate that COX-2 is a
novel direct target of miR-199a.
HIF-1α directly regulates COX-2 at the
transcriptional level. We previously found
that HIF-1α can be strongly induced by acute
arsenic treatment in prostate cancer cells
under normoxia condition (Gao et al. 2004).
In this study, we observed that both HIF-1α
and COX-2 expression levels were dramatically up-regulated in AsT cells. We speculate whether there is an interaction between
HIF-1α and COX-2 in this context. The
COX-2 promoter contains several HREs, one
of which we predicted to be functional (Jiang
et al. 2009). In the present study, we first
investigated whether HIF-1α is required for
arsenic-induced COX-2 expression. COX-2
mRNA and protein levels in BEAS-2B cells
were up-regulated under the hypoxia condition, whereas knockdown of HIF-1α by
specific siRNA almost completely reversed
the induction (Figures 4A-B). This indicates
AsT
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more than 100-fold lower in AsT cells, we
reason that arsenic plays a major role in the
suppression of miR-199a expression.
miR-199a inhibits arsenic-induced angiogenesis in vitro and in vivo. Our earlier study
(He et al. 2013a) showed that miR-199a processes an anti-angiogenic property in ovarian
cancer cells. We then investigated the functional effect of miR-199a in arsenic-induced
angiogenesis by performing a tube formation assay in vitro. As shown in Figure 2A,
tube formation was strongly induced when
cultured in conditioned medium prepared
from AsT cells as compared with its parental control BEAS-2B cells. Transient transfection of miR-199a in AsT cells decreased
tube formation by 40%. We next investigated the angiogenic effect of miR-199a
in vivo. First, we established AsT cells stably expressing miR-199a by transducing
lentivirus-carrying miR-199a-RFP. Then we
generated xenograft tumors by injecting the
stable cells AsT/miR-cont and AsT/miR-199a
subcutaneously in nude mice and allowed
tumors to grow for 6 weeks. Overexpression
of miR-199a decreased the tumor weight by
50% as compared with negative control cells
(Figure 2B). The number of microv essels
indicated by the endothelial marker CD31
staining in miR-199a–overexpressing tumors
was significantly lower than in the control
(Figure 2C). As in normal blood vessels,
tumor vessels consist of endothelial cells,
mural cells (pericytes and smooth muscle
cells), and basement membrane (Baluk
et al. 2003). The expression of α-SMA was
restricted to vascular smooth muscle cells
and co-localized with CD31 (Figure 2D).
Interestingly, we noticed that blood vessels
from AsT/miR-199a tumors had many more
mural cells reflected by α-SMA immuno
reactivities than AsT/miR-cont tumors,
suggesting that miR-199a decreases arsenicinduced tumor angiogenesis but promotes
blood vessel maturation (Figure 2E).
miR-199a directly targets both HIF-1α
and COX-2. HIF-1 is one of the major
pro-angiogenic factors through inducing
transcriptional activation of vascular endothelial growth factor (VEGF) (Semenza
2000). Another potent angiogenic activator
for tumor angiogenesis is COX-2, which is
a rate-limiting enzyme in the conversion of
arachadonic acid precursors in the cell membrane into PGE 2 (Xue and Shah 2013).
COX-2 and HIF-1α expression are frequently regulated by similar stimuli and control similar processes within the cells (Gately
2000; Liu et al. 1999). In the present study,
we observed that basal levels of HIF-1α
and COX-2 under normoxia were markedly up-regulated in AsT cells (Figure 3A).
Rane et al. (2009) reported that miR-199a
directly targets HIF-1α in cardiac myocytes.
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Figure 3. miR-199a directly targets both HIF-1α and COX-2. (A) Total proteins prepared from AsT cells and
BEAS-2B (B2B) cells were used to determine protein levels of COX and HIF-1α by Western blotting analysis. (B) AsT cells were transiently transfected with 25-nM miR-cont or miR-199a precursors for 72 hr, followed by Western blotting analysis. (C, D) Sequence alignment of human miR-199a sequence with 3´ UTR
region of COX-2. Data are presented as mean ± SE and analyzed by Student’s t-test. (E) COX-2 protein levels in tumor tissues (n = 10/group) were determined by Western blotting analysis. Representative samples
are shown.
*p < 0.05, compared with control cells.
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that hypoxia stimulates COX-2 expression
via HIF-1α. We further measured the concentration of COX-2 product, PGE2, with
the same treatments. Both BEAS-2B cells
and AsT cells produced more PGE2 under
hypoxia. Conversely, knockdown of HIF-1α
decreased PGE2 concentration with hypoxic
treatment (Figure 4C). To determine if there
is a direct interaction between HIF-1α and
COX-2 promoter, we performed the ChIP
assay. BEAS-2B cells were cultured in hypoxic
chamber for 24h and were subjected to
ChIP assay. As shown in Figure 4D, antibody against HIF-1α was able to pull down
COX-2 promoter suggesting the association
between HIF-1α and COX-2 gene. The earlier findings in our group predicted that one
of HRE (-576/-584) in the COX-2 promoter
would be functional (Jiang et al. 2009). We
validated the binding sites by constructing COX-2 promoter luciferase reporters
with wild-type or mutant HRE. As shown
in Figure 4E, hypoxia stimulated COX-2

Relative COX-2
mRNA level

5

transcriptional activity measured by luciferase
activity in BEAS-2B cells transfected with
wild-type reporter. Conversely, BEAS-2B
cells transfected with mutant reporter weren’t
affected by hypoxia. Furthermore, co-transfection of HIF-1α with the wild-type reporter
similarly promoted COX-2 transcription while co-transfection with the mutant
reporter did not affect the luciferase activities
(Figure 4F). Collectively, these data support
that HIF-1α directly regulates COX-2 at the
transcriptional level.
miR-199a inhibits arsenic-induced
angiogenesis via COX-2 expression. To determine the role of COX-2 in arsenic-induced
angiogenesis, we knocked down COX-2 to
evaluate the angiogenesis response using
the CAM assay (Figure 5A). We observed a
dramatic decrease of angiogenic potential in
COX-2 knockdown cells (Figure 5B). To test
whether the overexpression of COX-2 without miR‑199a binding sites is able to reverse
miR‑199a–inhibited angiogensis in AsT cells,
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Figure 4. HIF-1α directly regulates COX-2 expression at the transcriptional level. (A,B) BEAS-2B (B2B)
cells were incubated under normoxic or hypoxic condition (1% oxygen) for 24 hr or transfected with 50 nM
of a siRNA scramble control or a siRNA SMARTpool against HIF-1α for 72 hr as indicated. The mRNA levels (A) and protein levels (B) of COX-2 were determined by SYBR-green RT-qPCR or Western blotting analysis, respectively. (C) The concentrations of PGE2 in B2B cells and AsT cells were determined by ELISA.
(D) B2B cells were cultured under hypoxia for 24 hr and were subjected to the ChIP assay using antibodies
against IgG or HIF-1α. The antibody-promoter binding signals were analyzed by SYBR-qPCR. (E) B2B cells
were co-transfected with COX-2 luciferase reporters with wild-type or mutant HIF-1α binding sites and
β-gal plasmid. Cells were incubated under normoxia or hypoxia 24 hr before harvest. (F) B2B cells were
co-transfected with COX-2 wild-type or mutant reporters, HIF-1α plasmid or vector, and β-gal plasmid.
Luciferase activity assay was performed 60 hr after transfection. Data are presented as mean ± SE of
three independent experiments and analyzed by one-way ANOVA.
*p < 0.05, compared with control. #p < 0.05, compared with scrambled control.

Environmental Health Perspectives •

volume

122 | number 3 | March 2014

we established stable AsT cells overexpressing
COX2 by transducing lentivirus carrying
COX-2 cDNA without 3´UTR region. We
observed that forced expression of COX-2
completely reversed the inhibitory effect of
miR-199a in angiogenesis (Figure 5C). Taken
together, these results suggest that miR-199a
inhibits arsenic-induced angiogenesis by
directly targeting COX-2 expression.
ROS induce COX-2 pathway by suppressing miR-199a in AsT cells. Induction
of ROS in cells is closely related with heavy
metal exposure including arsenic, chromium,
and cadmium (Azad et al. 2010; Huang
et al. 2004; Wang et al. 2012). We previously observed that AsT cells produced higher
ROS (Carpenter et al. 2011). In addition,
our earlier findings indicate that miR-199a
is a ROS responsive miRNA in which ROS
inhibit miR-199a expression through increasing the promoter methylation of miR-199a
gene by DNA methyltransferase 1 (He et al.
2012b). In this study, we found that ROS
treatment increased COX-2 expression,
whereas the ROS scavenger catalase decreased
COX-2 expression (Figure 6A). To investigate whether ROS are upstream signals for
inhibiting miR-199a expression, we treated
AsT cells stably overe xpressing miR-199a
and AsT control cells with H2O2. We found
that H 2O 2–induced COX-2 expression in
AsT/miR-cont cells, but no induction was
observed in AsT/miR-199a cells (Figure 6B).
The strong links between the aberration of
miRNAs profiles and carcinogenesis, cancer
development, prognosis and chemoresistance
have been confirmed by a plethora of bench
and clinical studies (reviewed by Iorio and
Croce 2012). In this study, we identified that
exposure to arsenic induced the suppression of
miR-199a expression, which led to increased
angiogenesis responses and tumor growth.
The process of angiogenesis normally
occurs in the embryo, placenta, and during
menstrual cycle and wound-healing (Patella
and Rainaldi 2012). However, under pathological situations such as cancer, the same
angiogenic signaling pathways in tumors
are induced in order to obtain the sufficient
blood supply for tumor growth. A number of
miRNAs have been reported to be involved
in blood vessel development and angiogenesis by directly or indirectly regulating
pro-angiogenic factors or anti-angiogenic factors (Hua et al. 2006; Poliseno et al. 2006;
Urbich et al. 2008). Our previous study (He
et al. 2013a) showed that miR-199a inhibits
tumor angiogenesis by targeting ERBB2 and
ERBB3 thus suppressing their downstream
VEGF in ovarian cancer cells. In the context
of arsenic-induced transformation, miR-199a
showed strong anti-angiogenic properties not
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only by directly targeting HIF-1α but also
another proangiogenic factor COX-2, which
highlights the important role of miR-199a in
angiogenesis. Tumor vessels are leaky, immature, or morphologically abnormal because of
the absent or incomplete basement membrane
and mural cells (pericytes and smooth muscle
cells). Failure of tumor vessels to recruit a
normal coat of mural cells may contribute to
the abnormality of vessels (Abramsson et al.
2002). Berthod et al. (2012) showed that
α-SMA expressing cells were present around
capillaries and can thus act as a pericyte
marker. Interestingly, we found that miR199a can not only reduce the total number
of microvessels in tumors but also promote
vascular maturation as indicated by the higher
α-SMA staining.
HIF-1α signaling plays a critical role in
tumor metastasis, invasion, metabolism, and,
especially, angiogenesis (Covello and Simon
2004; Lum et al. 2007). We found that the
baseline of HIF-1α expression, which is
oxygen independent, was dramatically upregulated in arsenic-transformed cells. The
underlying mechanism might be the activation
of thymoma viral oncogene (AKT), mitogenactivated protein kinase (ERK), mechanistic
target of rapamycin (serine/threonine kinase;
mTOR), and ribosomal protein S6 kinase,
polypeptide 1 (p70S6K1) genes, as suggested
by our earlier results (Carpenter et al. 2011).
A recent study reported that overexpression
of miR-199a inhibited the hypoxia-induced
cell proliferation in non-small cell lung
cancer by suppressing HIF-1α (Ding et al.
2013). Oltipraz, a cancer chemopreventive
agent, has anti-angiogenic property mediated
by miR-199a induction and HIF-1α inhibition (Kang et al. 2012). Consistent with
the report of Kang et al. (2012), our results
show that miR-199a suppression by arsenic
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other studies (Csiki et al. 2006; Kaidi et al.
2006), both protein-DNA binding assay
and luciferase reporter assay confirmed that
HIF-1α directly regulates COX-2 expression

H2O2
Catalase

–
–

–
+

in parental BEAS-2B cells. This result along
with data that PGE2 can stimulate VEGF
expression through the activation of HIF-1α
(Greenhough et al. 2009) suggests a positivefeedback between HIF-1α and COX-2 in
arsenic-induced angiogenesis. The findings
also indicate that miR-199a may have high
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targeting both HIF-1α and COX-2. In addition, miR-199a-3p has also been reported to
target COX-2 in human chondrocytes (Akhtar
and Haqqi 2012). Because miR-199a-3p and
miR-199a-5p (miR-199a) are derived from
the same precursor, the expression levels of
both miRNAs may be somewhat regulated
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by the same mechanism(s). Further investigation of the upstream molecules that may indirectly modulate COX-2 expression via both
miRNAs in the future is of interest.
Overproduction of ROS is closely related
to heavy metal–mediated carcinogenesis (Lee
et al. 2012). Oxidative stress was reported
as a mediator of arsenic-induced cell transformation and carcinogenesis (Carpenter
et al. 2011; Wang et al. 2012). In addition,
ROS can activate HIF-1α and COX-2 in
various contexts (Bonello et al. 2007; Chen
et al. 2012). However, the mechanism under
lying how ROS regulate HIF-1α and COX-2
remains to be investigated. Here, we provide
a link in which repression of miR-199a by
arsenic-induced ROS activates HIF-1α and
COX-2 expression.
We found similar miR-199a suppression
and HIF-1α/COX-2 activation in Cr (VI)–
transformed cells (see Supplemental Material,
Figure S3). Further investigation is needed
to determine whether the same pathway is
generally activated in other metal-induced
cell transformation.

Conculsions
The present study provides a new mechanism of arsenic-induced tumor angiogenesis
and tumor growth. Arsenic-induced ROS
inhibit miR-199a expression via DNMT1mediated DNA methylation. The repression
of miR-199a expression results in induction
of HIF-1α and COX-2. In addition, the
bidirectional regulations between HIF-1α
and COX-2 forming a positive feedback further promote tumor angiogenesis and tumor
growth (Figure 6C). Our findings may have
clinical implication in targeted therapy for
arsenic-induced lung cancer in the future.
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